Piera Capranzano

8.0k total citations · 2 hit papers
140 papers, 4.1k citations indexed

About

Piera Capranzano is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Piera Capranzano has authored 140 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Cardiology and Cardiovascular Medicine, 83 papers in Surgery and 25 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Piera Capranzano's work include Coronary Interventions and Diagnostics (65 papers), Antiplatelet Therapy and Cardiovascular Diseases (55 papers) and Cardiac Valve Diseases and Treatments (46 papers). Piera Capranzano is often cited by papers focused on Coronary Interventions and Diagnostics (65 papers), Antiplatelet Therapy and Cardiovascular Diseases (55 papers) and Cardiac Valve Diseases and Treatments (46 papers). Piera Capranzano collaborates with scholars based in Italy, United States and Spain. Piera Capranzano's co-authors include Davide Capodanno, Corrado Tamburino, Dominick J. Angiolillo, Theodore A. Bass, Giuseppe Gargiulo, Marco Barbanti, Anna Caggegi, Giuseppe Andò, M. Salvo and Glauco Cincotta and has published in prestigious journals such as Annals of Internal Medicine, Journal of the American College of Cardiology and European Heart Journal.

In The Last Decade

Piera Capranzano

134 papers receiving 4.0k citations

Hit Papers

European Society of Cardi... 2015 2026 2018 2022 2018 2015 100 200 300

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Piera Capranzano 3.4k 2.2k 902 687 597 140 4.1k
Lars Romer Krusell 3.3k 1.0× 2.2k 1.0× 1.6k 1.8× 594 0.9× 571 1.0× 92 4.9k
Anthony A. Bavry 3.3k 1.0× 2.1k 0.9× 1.1k 1.2× 577 0.8× 360 0.6× 138 4.3k
Martine Gilard 4.7k 1.4× 1.7k 0.8× 1.2k 1.3× 867 1.3× 1.4k 2.4× 201 5.8k
Pilar Jiménez‐Quevedo 3.9k 1.1× 3.0k 1.3× 1.1k 1.2× 1.0k 1.5× 508 0.9× 212 4.8k
Marino Labinaz 2.9k 0.8× 1.6k 0.7× 1.1k 1.2× 698 1.0× 515 0.9× 169 4.5k
Steen Dalby Kristensen 3.2k 0.9× 1.8k 0.8× 1.1k 1.2× 403 0.6× 239 0.4× 192 4.7k
Carlos Macaya 4.9k 1.4× 3.7k 1.7× 1.8k 2.0× 1.4k 2.0× 507 0.8× 231 6.4k
Nasser Lakkis 6.3k 1.9× 2.2k 1.0× 1.8k 2.0× 459 0.7× 623 1.0× 111 7.3k
Augustin DeLago 2.7k 0.8× 1.8k 0.8× 1.7k 1.9× 333 0.5× 203 0.3× 35 4.1k
E. Magnus Ohman 3.3k 1.0× 3.0k 1.3× 1.0k 1.2× 458 0.7× 246 0.4× 79 5.3k

Countries citing papers authored by Piera Capranzano

Since Specialization
Citations

This map shows the geographic impact of Piera Capranzano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piera Capranzano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piera Capranzano more than expected).

Fields of papers citing papers by Piera Capranzano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piera Capranzano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piera Capranzano. The network helps show where Piera Capranzano may publish in the future.

Co-authorship network of co-authors of Piera Capranzano

This figure shows the co-authorship network connecting the top 25 collaborators of Piera Capranzano. A scholar is included among the top collaborators of Piera Capranzano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piera Capranzano. Piera Capranzano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greco, Antonio, Lorenzo Scalia, Claudio Laudani, et al.. (2024). Downstream cangrelor versus upstream ticagrelor in patients with ST-segment elevation myocardial infarction: A propensity score-matched analysis. International Journal of Cardiology. 418. 132660–132660. 1 indexed citations
2.
Capranzano, Piera, David J. Moliterno, & Davide Capodanno. (2024). Aspirin-free antiplatelet strategies after percutaneous coronary interventions. European Heart Journal. 45(8). 572–585. 12 indexed citations
3.
Luca, Leonardo De, Paolo Calabrò, Piera Capranzano, et al.. (2023). Safety of cangrelor and transition to oral P2Y12 inhibitors in patients undergoing percutaneous coronary intervention: the ARCANGELO study. European Heart Journal Open. 3(4). oead076–oead076. 12 indexed citations
4.
Capranzano, Piera & Dominick J. Angiolillo. (2021). Antithrombotic Management of Elderly Patients With Coronary Artery Disease. JACC: Cardiovascular Interventions. 14(7). 723–738. 25 indexed citations
5.
Capranzano, Piera, Bruno Francaviglia, Maria Radu, et al.. (2018). Lipid Plaque Modification During Resorption of Absorb Bioresorbable Scaffold. JACC: Cardiovascular Interventions. 11(20). 2123–2124. 2 indexed citations
6.
Buccheri, Sergio, Giuseppe Venuti, Paolo D’Arrigo, et al.. (2017). Clinical Outcomes Following Intravascular Imaging-Guided Versus Coronary Angiography–Guided Percutaneous Coronary Intervention With Stent Implantation. JACC: Cardiovascular Interventions. 10(24). 2488–2498. 161 indexed citations
7.
Andò, Giuseppe & Piera Capranzano. (2016). Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with chronic kidney disease: A systematic review and network meta-analysis. International Journal of Cardiology. 231. 162–169. 66 indexed citations
8.
Tamburino, Corrado, Piera Capranzano, Tommaso Gori, et al.. (2016). 1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds Versus Everolimus-Eluting Stents. JACC: Cardiovascular Interventions. 9(5). 440–449. 19 indexed citations
9.
Ohno, Yohei, Guilherme F. Attizzani, Davide Capodanno, et al.. (2015). Longitudinal Elongation, Axial Compression, and Effects on Strut Geometry of Bioresorbable Vascular Scaffolds. JACC: Cardiovascular Interventions. 8(3). e35–e37. 2 indexed citations
10.
Gargiulo, Giuseppe, Giovanni Longo, Davide Capodanno, et al.. (2015). Cyphering the Mechanism of Late Failure of Bioresorbable Vascular Scaffolds in Percutaneous Coronary Intervention of the Left Main Coronary Artery. JACC: Cardiovascular Interventions. 8(6). e95–e97. 1 indexed citations
11.
Capodanno, Davide, Marco Barbanti, Corrado Tamburino, et al.. (2014). A Simple Risk Tool (the OBSERVANT Score) for Prediction of 30-Day Mortality After Transcatheter Aortic Valve Replacement. The American Journal of Cardiology. 113(11). 1851–1858. 114 indexed citations
12.
Attizzani, Guilherme F., Yohei Ohno, Davide Capodanno, et al.. (2014). Extended Use of Percutaneous Edge-to-Edge Mitral Valve Repair Beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) Criteria. JACC: Cardiovascular Interventions. 8(1). 74–82. 73 indexed citations
13.
Capranzano, Piera, et al.. (2013). Personalizing oral anticoagulant treatment in patients with atrial fibrillation. Expert Review of Cardiovascular Therapy. 11(8). 959–973. 13 indexed citations
14.
Ueno, Masafumi, José Luis Ferreiro, Bhaloo Desai, et al.. (2012). Cigarette Smoking Is Associated With a Dose-Response Effect in Clopidogrel-Treated Patients With Diabetes Mellitus and Coronary Artery Disease. JACC: Cardiovascular Interventions. 5(3). 293–300. 40 indexed citations
15.
Angiolillo, Dominick J., Esther Bernardo, David Vivas, et al.. (2011). Impact of Insulin Receptor Substrate-1 Genotypes on Platelet Reactivity and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease. Journal of the American College of Cardiology. 58(1). 30–39. 45 indexed citations
16.
Ueno, Masafumi, José Luis Ferreiro, Kodlipet Dharmashankar, et al.. (2011). SERUM COTININE LEVELS ARE ASSOCIATED WITH INCREASED CLOPIDOGREL-INDUCED ANTIPLATELET EFFECTS IN PATIENTS WITH DIABETES MELLITUS AND CORONARY ARTERY DISEASE. Journal of the American College of Cardiology. 57(14). E1919–E1919. 1 indexed citations
17.
Angiolillo, Dominick J., Esther Bernardo, Piera Capranzano, et al.. (2010). IMPACT OF IRS-1 GENOTYPES ON PLATELET REACTIVITY AND CARDIOVASCULAR OUTCOMES IN TYPE 2 DIABETES MELLITUS PATIENTS WITH CORONARY ARTERY DISEASE. Journal of the American College of Cardiology. 55(10). A207.E1953–A207.E1953. 1 indexed citations
18.
Tamburino, Corrado, Piera Capranzano, Davide Capodanno, et al.. (2010). Plaque Distribution Patterns in Distal Left Main Coronary Artery to Predict Outcomes After Stent Implantation. JACC: Cardiovascular Interventions. 3(6). 624–631. 24 indexed citations
19.
Ueno, Masafumi, José Luis Ferreiro, Kodlipet Dharmashankar, et al.. (2010). CORRELATION BETWEEN THE VERIFYNOW P2Y12 ASSAY AND LIGHT TRANSMITTANCE AGGREGOMETRY TO MEASURE PLATELET P2Y12 RECEPTOR INHIBITION IN PATIENTS ON CLOPIDOGREL THERAPY. Journal of the American College of Cardiology. 55(10). A206.E1946–A206.E1946. 1 indexed citations
20.
Capodanno, Davide, Piera Capranzano, M. Salvo, et al.. (2009). Usefulness of SYNTAX Score to Select Patients With Left Main Coronary Artery Disease to Be Treated With Coronary Artery Bypass Graft. JACC: Cardiovascular Interventions. 2(8). 731–738. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026